Pacira BioSciences, Inc. PCRX Revenue
Revenue at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s revenue?
- Pacira BioSciences, Inc. (PCRX) reported revenue of $177.38M in Q1 2026.
- How has Pacira BioSciences, Inc.'s revenue changed year-over-year?
- Pacira BioSciences, Inc.'s revenue increased by 5.0% year-over-year, from $168.92M to $177.38M.
- What is the long-term trend for Pacira BioSciences, Inc.'s revenue?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s revenue has grown at a 7.6% compound annual growth rate (CAGR), from $541.53M to $726.41M.